CD19 and neoplasm: Although long-term persistence of CD19 CAR T cells is important to achieve a durable anti-tumor immunity to prevent tumor recurrence, these cells can cause severe B cell aplasia, increased infectious complications [31,32], and cell fratricide due to the shared antigen expression on malignant and non-malignant T cells.